Personalising whole genome sequencing doubles diagnosis of rare diseases


Tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases, finds a new study led by UCL researchers.

Get a tech upgrade the green way with 74% off this refurbished MacBook Air

Previous article

Study suggests anti-PF4 antibodies may play a role in the severe multiorgan disease manifestations of COVID-19

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations